Kyle Weant to Drug Utilization Review
This is a "connection" page, showing publications Kyle Weant has written about Drug Utilization Review.
Connection Strength
0.099
-
Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center. Pharmacotherapy. 2012 May; 32(5):433-40.
Score: 0.099